{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["61(6)"],"submitter":["Liu X"],"pubmed_abstract":["KRAS is a biomarker for non‑small cell lung cancer‑targeted therapy, but there is currently no effective KRAS‑targeting medication. Realgar is an impelling anticancer drug, however its significance in KRAS mutant lung cancer is uncertain. According to our findings, the IC<sub>50</sub> of H23 (KRAS mutant) cells is 2.99 times lower than that of H1650 (non‑KRAS mutant) cells. Flow cytometry and the Hoechst 33258 staining assay revealed that H1650 cells treated with 4 µg/ml realgar had an apoptotic rate of 8.2%, while H23 cells had a rate of 21.46%. Accordingly, realgar was more sensitive to KRAS mutant cells. Transcriptome sequencing test indicated that there were 481 different expression genes in H23 cells treated with realgar. In H23 cells treated with realgar, mitochondria shrank, inner m"],"journal":["International journal of oncology"],"pagination":["157"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9635866"],"repository":["biostudies-literature"],"pubmed_title":["Realgar‑induced KRAS mutation lung cancer cell death via KRAS/Raf/MAPK mediates ferroptosis."],"pmcid":["PMC9635866"],"pubmed_authors":["Liu X","Xu L","Ren W","Dong J","Su J","Liu D","Hai Y","Hou W"],"additional_accession":[]},"is_claimable":false,"name":"Realgar‑induced KRAS mutation lung cancer cell death via KRAS/Raf/MAPK mediates ferroptosis.","description":"KRAS is a biomarker for non‑small cell lung cancer‑targeted therapy, but there is currently no effective KRAS‑targeting medication. Realgar is an impelling anticancer drug, however its significance in KRAS mutant lung cancer is uncertain. According to our findings, the IC<sub>50</sub> of H23 (KRAS mutant) cells is 2.99 times lower than that of H1650 (non‑KRAS mutant) cells. Flow cytometry and the Hoechst 33258 staining assay revealed that H1650 cells treated with 4 µg/ml realgar had an apoptotic rate of 8.2%, while H23 cells had a rate of 21.46%. Accordingly, realgar was more sensitive to KRAS mutant cells. Transcriptome sequencing test indicated that there were 481 different expression genes in H23 cells treated with realgar. In H23 cells treated with realgar, mitochondria shrank, inner m","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Dec","modification":"2025-04-03T22:23:39.535Z","creation":"2025-02-19T00:31:47.358Z"},"accession":"S-EPMC9635866","cross_references":{"pubmed":["36321791"],"doi":["10.3892/ijo.2022.5447"]}}